Riedel Thyroiditis

被引:15
|
作者
Zala, Aakansha [1 ,2 ]
Berhane, Thomas [1 ]
Juhlin, C. Christofer [3 ,4 ]
Calissendorff, Jan [5 ,6 ]
Falhammar, Henrik [1 ,5 ,6 ,7 ]
机构
[1] Royal Darwin Hosp, Dept Endocrinol, Tiwi, NT 0810, Australia
[2] Gold Coast Univ Hosp, Dept Endocrinol, Southport, Qld 4215, Australia
[3] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Pathol & Cytol, S-17177 Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, S-17177 Stockholm, Sweden
[6] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden
[7] Menzies Sch Hlth Res, Darwin, NT 0810, Australia
来源
关键词
Riedel thyroiditis; Riedel thyroid; fibrosing thyroiditis; outcomes; diagnosis; treatment; FIBROSING HASHIMOTOS-THYROIDITIS; FINE-NEEDLE-ASPIRATION; FIBROUS THYROIDITIS; MULTIFOCAL FIBROSCLEROSIS; RETROPERITONEAL FIBROSIS; SCLEROSING CHOLANGITIS; ORBITAL INVOLVEMENT; SUBACUTE THYROIDITIS; MULTINODULAR GOITER; TAMOXIFEN THERAPY;
D O I
10.1210/clinem/dgaa468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Riedel thyroiditis (RT) is a rare inflammatory autoimmune disease that is often a clinically diagnostic dilemma because of its insidious presentation and nonspecific symptoms. Objective: The aim of the present systematic review and meta-analysis is to clarify the presentation, management, and outcomes of RT. Study Selection: A systematic search of PubMed/MEDLINE and Web of Science was conducted to identify relevant reports published up to September 2019. Data Extraction: First author, country, patient sex, ethnicity, presentation, biochemical status, duration of symptoms, histology, treatment, follow-up duration, and short- and long-term outcomes. Data Synthesis: Data from 212 RT patients were retrieved. The mean age was 47 years with a predominantly female population (81%). Neck swelling (89%), dyspnea (50%), and neck pain (41%) were the most common presenting symptoms. Inflammatory markers were elevated in 70% to 97% and thyroid antibody positivity was present in less than 50%. Up to 82% underwent surgical intervention, with the most common being total thyroidectomy in 34% of individuals. Glucocorticoids were used in 70% of individuals with median duration 3 months. Prognosis was reasonable with 90% having resolution or improvement of symptoms. Conclusions: This analysis is the largest and most comprehensive to date of RT and provides clinicians with vital information on the common presentation features that may alert to the diagnosis and highlight management options.
引用
收藏
页码:E3469 / E3481
页数:13
相关论文
共 50 条
  • [41] Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma
    Hong, Ji Taek
    Lee, Jung Hwan
    Kim, So Hun
    Hong, Seong Bin
    Nam, Moonsuk
    Kim, Yong Seong
    Chu, Young Chae
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2013, 28 (02): : 236 - 241
  • [42] Tamoxifen Treatment for Riedel's Thyroiditis: A Case Report
    Karakilic, Ersen
    Saygili, Emre Sedar
    Yildiz, Oezlem
    Kuyucu, Asli
    ENDOCRINOLOGY RESEARCH AND PRACTICE, 2023, 27 (04): : 245 - 247
  • [43] Sarcoma of the thyroid region mimicking Riedel's thyroiditis
    Torres-Montaner, A
    Beltrán, M
    de la Osa, AR
    Oliva, H
    JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (07) : 570 - 572
  • [44] Riedel's thyroiditis: impact and strategy of a challenging surgery
    Lorenz, Kerstin
    Gimm, Oliver
    Holzhausen, Hans Juergen
    Kittel, Stephan
    Ukkat, Joerg
    Thanh, Phuong Nguyen
    Brauckhoff, Michael
    Dralle, Henning
    LANGENBECKS ARCHIVES OF SURGERY, 2007, 392 (04) : 405 - 412
  • [45] A rare case of orbital involvement in Riedel’s thyroiditis
    V. Egsgaard Nielsen
    P. Hecht
    A. S. Krogdahl
    P. B. Andersen
    L. Hegedüs
    Journal of Endocrinological Investigation, 2003, 26 : 1032 - 1036
  • [46] Riedel’s thyroiditis: clinical presentation, treatment and outcomes
    Henrik Falhammar
    Carl Christofer Juhlin
    Caroline Barner
    Sergiu-Bogdan Catrina
    Christos Karefylakis
    Jan Calissendorff
    Endocrine, 2018, 60 : 185 - 192
  • [47] Rituximab: a novel treatment for refractory Riedel's thyroiditis
    Hunt, Leanne
    Harrison, Barney
    Bull, Matthew
    Stephenson, Tim
    Allahabadia, Amit
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2018,
  • [48] IgG4-related Riedel's thyroiditis
    Lopez-Sanchez, Geraldine
    Reyna-Villasmil, Eduardo
    MEDICINA CLINICA, 2016, 147 (01): : 44 - 45
  • [49] Graves' Disease after Unilateral Riedel's Thyroiditis
    McIver, Bryan
    Fatourechi, Mitra M.
    Hay, Ian D.
    Fatourechi, Vahab
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06): : 2525 - 2526
  • [50] Riedel's thyroiditis: clinical presentation, treatment and outcomes
    Falhammar, Henrik
    Juhlin, Carl Christofer
    Barner, Caroline
    Catrina, Sergiu-Bogdan
    Karefylakis, Christos
    Calissendorff, Jan
    ENDOCRINE, 2018, 60 (01) : 185 - 192